These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
82 related items for PubMed ID: 15674949
1. Recombinant growth hormone therapy for X-linked hypophosphatemia in children. Huiming Y, Chaomin W. Cochrane Database Syst Rev; 2005 Jan 25; (1):CD004447. PubMed ID: 15674949 [Abstract] [Full Text] [Related]
2. Recombinant growth hormone therapy for X-linked hypophosphatemia in children. Smith S, Remmington T. Cochrane Database Syst Rev; 2021 Oct 07; 10(10):CD004447. PubMed ID: 34618915 [Abstract] [Full Text] [Related]
3. The effect of recombinant human growth hormone in children with X-linked hypophosphatemia. Seikaly MG, Brown R, Baum M. Pediatrics; 1997 Nov 07; 100(5):879-84. PubMed ID: 9346990 [Abstract] [Full Text] [Related]
4. Long-term growth hormone treatment in children with renal hypophosphatemic rickets: effects on growth, mineral metabolism, and bone density. Saggese G, Baroncelli GI, Bertelloni S, Perri G. J Pediatr; 1995 Sep 07; 127(3):395-402. PubMed ID: 7658269 [Abstract] [Full Text] [Related]
5. X-linked hypophosphatemia: effects of treatment with recombinant human growth hormone. Reusz GS, Miltényi G, Stubnya G, Szabó A, Horváth C, Byrd DJ, Péter F, Tulassay T. Pediatr Nephrol; 1997 Oct 07; 11(5):573-7. PubMed ID: 9323282 [Abstract] [Full Text] [Related]
7. Recombinant growth hormone in children and adolescents with Turner syndrome. Cave CB, Bryant J, Milne R. Cochrane Database Syst Rev; 2003 Oct 07; (3):CD003887. PubMed ID: 12917993 [Abstract] [Full Text] [Related]
8. A trial of growth hormone therapy in well-controlled hypophosphataemic rickets. Cameron FJ, Sochett EB, Daneman A, Kooh SW. Clin Endocrinol (Oxf); 1999 May 07; 50(5):577-82. PubMed ID: 10468922 [Abstract] [Full Text] [Related]
9. Growth pattern in children with X-linked hypophosphatemia treated with burosumab and growth hormone. Ertl DA, Le Lorier J, Gleiss A, Trabado S, Bensignor C, Audrain C, Zhukouskaya V, Coutant R, Berkenou J, Rothenbuhler A, Haeusler G, Linglart A. Orphanet J Rare Dis; 2022 Nov 12; 17(1):412. PubMed ID: 36371259 [Abstract] [Full Text] [Related]
10. Recombinant growth hormone therapy for cystic fibrosis in children and young adults. Thaker V, Haagensen AL, Carter B, Fedorowicz Z, Houston BW. Cochrane Database Syst Rev; 2015 May 20; (5):CD008901. PubMed ID: 25991406 [Abstract] [Full Text] [Related]
11. Recombinant growth hormone therapy for cystic fibrosis in children and young adults. Thaker V, Haagensen AL, Carter B, Fedorowicz Z, Houston BW. Cochrane Database Syst Rev; 2013 Jun 05; 6(6):CD008901. PubMed ID: 23737090 [Abstract] [Full Text] [Related]
16. Recombinant growth hormone for idiopathic short stature in children and adolescents. Bryant J, Cave C, Milne R. Cochrane Database Syst Rev; 2003 Jul 19; (4):CD004440. PubMed ID: 14584015 [Abstract] [Full Text] [Related]
17. Growth hormone for children with chronic kidney disease. Hodson EM, Willis NS, Craig JC. Cochrane Database Syst Rev; 2012 Feb 15; 2012(2):CD003264. PubMed ID: 22336787 [Abstract] [Full Text] [Related]
18. Growth hormone therapy for people with thalassaemia. Ngim CF, Lai NM, Hong JY, Tan SL, Ramadas A, Muthukumarasamy P, Thong MK. Cochrane Database Syst Rev; 2020 May 28; 5(5):CD012284. PubMed ID: 32463488 [Abstract] [Full Text] [Related]